Memphis Pharmaceuticals

مادة اعلانية

Latest Update: 13 Jan 2026 14:02 Abu Dhabi Time.

Market Status: Opened

MPCI

Memphis Pharmaceuticals

147.00

EGP

1.000

0.68%

Open

146.00

Prev Close

146.00

PX_VOLUME

122,213

MARKET CAP (M)

DAY RANGE

145.22 - 147.90

52 WEEKS

47.15 - 232.95

Stock Statistics

Yearly Change

186.35%

Listed Shares (Million)

22.75

Earnings Multiple

7.13

Average 30-day trading volume

283,289.56

Price-to-book ratio

5.63

Earnings Per Share

22.21

Previous Dividend Distribution

16.33

Dividend Yield

11.69%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		497.89	410.53	309.36	388.26	399.66	207.33	234.79	247.14	182.65
Gross Profit		203.53	176.48	130.23	189.82	187.25	70.43	75.84	100.90	53.12
Operating Income		173.60	145.15	98.94	136.20	149.06	51.45	45.44	64.59	26.64
Profit Margin		30.72	31.55	34.81	32.77	35.24	12.10	35.56	23.52	13.56

	Period Ending:	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Revenue		1,507.80	871.91	663.83	551.26	518.11
Gross Profit		683.78	300.29	212.95	149.39	164.98
Operating Income		528.91	188.12	98.85	71.04	36.24
Profit Margin		33.51	21.96	13.62	13.44	8.07

Balance Sheet

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		1,646.86	1,492.80	1,483.67	1,343.04	1,330.93	1,217.04	1,127.34	1,004.16	795.79
Total Liabilities		1,052.45	722.27	823.09	960.80	1,042.41	1,067.96	1,059.62	856.04	667.63
Total Equity		594.41	770.54	660.58	382.23	288.51	149.08	67.73	148.12	128.16

	Period Ending:	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Assets		1,492.80	1,217.04	785.66	560.29	431.58
Total Liabilities		722.27	1,067.96	680.70	523.65	469.77
Total Equity		770.54	149.08	104.95	36.64	-38.18

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

MPCI

Memphis Pharmaceuticals